Literature DB >> 12027565

Alpha-satellite DNA and vector composition influence rates of human artificial chromosome formation.

Brenda R Grimes1, Angela A Rhoades, Huntington F Willard.   

Abstract

Human artificial chromosomes (HACs) have been proposed as a new class of potential gene transfer and gene therapy vector. HACs can be formed when bacterial cloning vectors containing alpha-satellite DNA are transfected into cultured human cells. We have compared the HAC-forming potential of different sequences to identify features critical to the efficiency of the process. Chromosome 17 or 21 alpha-satellite arrays are highly competent HAC-forming substrates in this assay. In contrast, a Y-chromosome-derived alpha-satellite sequence is inefficient, suggesting that centromere specification is at least partly dependent on DNA sequence. The length of the input array is also an important determinant, as reduction of the chromosome-17-based array from 80 kb to 35 kb reduced the frequency of HAC formation. In addition to the alpha-satellite component, vector composition also influenced HAC formation rates, size, and copy number. The data presented here have a significant impact on the design of future HAC vectors that have potential to be developed for therapeutic applications and as tools for investigating human chromosome structure and function. (c)2002 Elsevier Science (USA).

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12027565     DOI: 10.1006/mthe.2002.0612

Source DB:  PubMed          Journal:  Mol Ther        ISSN: 1525-0016            Impact factor:   11.454


  47 in total

1.  Distribution of retroelements in centromeres and neocentromeres of maize.

Authors:  Rebecca J Mroczek; R Kelly Dawe
Journal:  Genetics       Date:  2003-10       Impact factor: 4.562

Review 2.  Artificial and engineered chromosomes: developments and prospects for gene therapy.

Authors:  Brenda R Grimes; Zoia Larin Monaco
Journal:  Chromosoma       Date:  2005-10-15       Impact factor: 4.316

3.  Progressive proximal expansion of the primate X chromosome centromere.

Authors:  Mary G Schueler; John M Dunn; Christine P Bird; Mark T Ross; Luigi Viggiano; Mariano Rocchi; Huntington F Willard; Eric D Green
Journal:  Proc Natl Acad Sci U S A       Date:  2005-07-19       Impact factor: 11.205

4.  A minimal CENP-A core is required for nucleation and maintenance of a functional human centromere.

Authors:  Yasuhide Okamoto; Megumi Nakano; Jun-ichirou Ohzeki; Vladimir Larionov; Hiroshi Masumoto
Journal:  EMBO J       Date:  2007-02-22       Impact factor: 11.598

5.  Flipping the centromere switch: reactivation of a dormant centromere in maize.

Authors:  Jennifer Mach
Journal:  Plant Cell       Date:  2009-07-14       Impact factor: 11.277

6.  α satellite DNA variation and function of the human centromere.

Authors:  Lori L Sullivan; Kimberline Chew; Beth A Sullivan
Journal:  Nucleus       Date:  2017-04-13       Impact factor: 4.197

7.  Centromeric retroelements and satellites interact with maize kinetochore protein CENH3.

Authors:  Cathy Xiaoyan Zhong; Joshua B Marshall; Christopher Topp; Rebecca Mroczek; Akio Kato; Kiyotaka Nagaki; James A Birchler; Jiming Jiang; R Kelly Dawe
Journal:  Plant Cell       Date:  2002-11       Impact factor: 11.277

Review 8.  The unique kind of human artificial chromosome: Bypassing the requirement for repetitive centromere DNA.

Authors:  Craig W Gambogi; Jennine M Dawicki-McKenna; Glennis A Logsdon; Ben E Black
Journal:  Exp Cell Res       Date:  2020-04-01       Impact factor: 3.905

9.  Functional epialleles at an endogenous human centromere.

Authors:  Kristin A Maloney; Lori L Sullivan; Justyne E Matheny; Erin D Strome; Stephanie L Merrett; Alyssa Ferris; Beth A Sullivan
Journal:  Proc Natl Acad Sci U S A       Date:  2012-07-30       Impact factor: 11.205

10.  Human centromeric chromatin is a dynamic chromosomal domain that can spread over noncentromeric DNA.

Authors:  Ai Leen Lam; Christopher D Boivin; Caitlin F Bonney; M Katharine Rudd; Beth A Sullivan
Journal:  Proc Natl Acad Sci U S A       Date:  2006-03-06       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.